The Latest Updates from ReSPECT Clinical Trials
ABTA 2024
Another great @the_abta National Conference! 🎗️🧠 A huge thank you to their organization for hosting this event and to all the patients and caregivers who came by our booth to learn about our ongoing ReSPECT Clinical Trials. For more information, please visit:...
Plus is at ABTA!
Come by our booth today and tomorrow at @the_abta national conference in Chicago! Our clinical and patient advocacy team will be on-site to share educational material and answer your questions about our ReSPECT Clinical Trials. 🌟
Patient Support Group HFTC
Join us at the @HeadfortheCure Patient Perspectives support group! We will discuss our ReSPECT-GBM clinical trial for Glioblastoma, patient resources, and upcoming events. Email courtney@headforthecure.org if you would like to attend.
Childhood Cancer Awareness Month 2024
September is #ChildhoodCancerAwarenessMonth and we want to raise awareness for pediatric #braincancer resources 💛 These advocacy groups have a wealth of knowledge so please follow & share to #patients & #caregivers: (More can be found on our website:...
Head for the Cure Texas
Come join us at the upcoming @HeadfortheCure 5K runs in San Antonio and Houston! It’s not too late to register as we join together in the fight against brain cancer. Plus Therapeutics will run (or walk) the races and have a booth on-site to provide education about our...
ABTA National Conference
We’re excited to exhibit at the ABTA National Conference! Visit our booth to learn more about our latest advancements in #braintumor treatment and support. Join us: http://abta.org/national-conference #BTSM #BrainTumorAwareness
Support Group Sessions
Mark your calendars! Our clinical and patient advocacy teams will be speaking at some upcoming @HeadfortheCure patient and caregiver events. Tune in to learn about Glioblastoma and our ongoing ReSPECT-GBM clinical trial. For more information and to sign up, click...
Symposium Replay
Now Streaming: Replay the live symposium by Plus Therapeutics presented at the 2024 SNO/ASCO CNS Metastases Conference in Denver, CO. Watch on YouTube: https://youtu.be/kOWF7ym0WSE
ReSPECT-LM Data from SNO/ASCO
Highlights include: > Respect-LM dosing shows continued feasibility and safety of up to 44 mCi of intrathecal Rhenium (186Re) Obisbemeda > High absorbed radiation doses, mean circulating tumor cell reductions, and median overall survival of 12 months continue to...
SNO/ASCO Presentations
Attending SNO/ASCO CNS Conference in Denver this week? So are we! Read the full details on our upcoming symposium, oral presentations, and posters: https://bit.ly/3LFxFMS...
SNO/ASCO Bronze Supporter
Plus Therapeutics is proud to be a Bronze Supporter and Exhibitor at the SNO / ASCO CNS Conference this year! Come by our booth, posters, and presentations we have going on throughout the conference. Detail including times and presentation titles:...
SNO/ASCO Symposium
You're Invited to our symposium "Emerging Novel Diagnostic and Therapeutic Approaches for Leptomeningeal Metastases," presented at the SNO/ASCO CNS conference in Denver. More information & RSVP: https://bit.ly/4bM777e "Emerging Novel Diagnostic and Therapeutic...
2024 SNO/ASCO Curtain Raiser
UPCOMING PRESENTATIONS: Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference and scheduled to present new data, highlighting progress in its therapeutics and diagnostics programs for Leptomeningeal Metastases Read the full details...
Radiotherapeutics Q&A
"Radiopharmaceutical therapy (RPT) is emerging as a safe and effective targeted approach to treating many types of cancer. In RPT, radiation is systemically or locally delivered. To learn more about emerging developments, Digital Journal spoke with Marc Hedrick, MD...
GBM Fight
"A lot of the battles that [GBM] picks are people that are truly going to fight back and give hope to the next patient..." ✊ Watch the full interview with Olympic Athlete & Brain Cancer Champion Scott Hamilton: https://bit.ly/4bKiufQ Social Media:...
Gordon Research Conference
Join us at the Gordon Research Conference: Radionuclide Theranostics for the Management of Cancer, being held July 7-12 in Newry, Maine, as Plus Therapeutics takes the stage. Presentation by Melissa Moore, Ph.D. Press Release: https://bit.ly/PSTV_PR...
GBMRO Podcast
We are proud to support @glioblastomaakagbm podcast by @glioblastomaresearch! Listen again to the episode "Power and Precision with Plus Therapeutics": https://spoti.fi/3W4O5Dl In their latest episode, they are joined by Holly Gainsboro, a grief specialist and founder...
OSU for ReSPECT-LM
❗NEW CLINICAL TRIAL INVESTIGATION SITE❗ We are pleased to announce the addition of Ohio State University in Columbus, Ohio to our ReSPECT-LM Clinical Trial with Principal Investigator Shirley Ong M.D.. This site is NOW ENROLLING patients. Learn More about Dr. Ong:...
Brain & Spine Metastasis Awareness Month
June is Brain & Spine Metastasis Awareness Month! 🧠🎗️ We want to continue to raise awareness for Leptomeningeal Metastases, which is diagnosed in approximately 110,000 cases per year in the U.S. Learn more about this metastatic cancer by visiting our Comprehensive...
SNMMI Presentation for LM
Plus Therapeutics presented data on its novel radioisotope rhenium-186 at the annual meeting of the Society of Nuclear Medicine & Molecular Imaging (SNMMI) in Toronto. Link to presentation: https://bit.ly/4bd9GyB An oral presentation titled, “Radiation Absorbed...
Contents
- 1 The Latest Updates from ReSPECT Clinical Trials
- 1.1 ABTA 2024
- 1.2 Plus is at ABTA!
- 1.3 Patient Support Group HFTC
- 1.4 Childhood Cancer Awareness Month 2024
- 1.5 Head for the Cure Texas
- 1.6 ABTA National Conference
- 1.7 Support Group Sessions
- 1.8 Symposium Replay
- 1.9 ReSPECT-LM Data from SNO/ASCO
- 1.10 SNO/ASCO Presentations
- 1.11 SNO/ASCO Bronze Supporter
- 1.12 SNO/ASCO Symposium
- 1.13 2024 SNO/ASCO Curtain Raiser
- 1.14 Radiotherapeutics Q&A
- 1.15 GBM Fight
- 1.16 Gordon Research Conference
- 1.17 GBMRO Podcast
- 1.18 OSU for ReSPECT-LM
- 1.19 Brain & Spine Metastasis Awareness Month
- 1.20 SNMMI Presentation for LM